Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Identifying and Incorporating into Practice Screening Tools for People with HIV who are Aging in the Ryan White HIV/AIDS Program
This HRSA HIV/AIDS Bureau national webinar featured two Ryan White HIV/AIDS Program (RWHAP) providers.
Resource updated 06/09/2022
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic
Recap of changes made in telehealth laws, regulations, and policies and corresponding efforts of healthcare systems, payers, and providers to modify their services to keep clients with HIV engaged in care provided by HRSA's Ryan White HIV/AIDS Program.Resource updated 06/09/2022
-
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
Moving Beyond Data Completeness: Ensuring RSR Data Reflect Services Being Provided
Review of 2021 RSR data and data quality issues.Resource updated 12/21/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Reflections on Black Women with HIV and Incarceration
Coming Home: Women, Race, Social Justice & HIV, a virtual learning experience that centered voices from the community of justice-involved Black women with HIV.Blog updated 11/29/2022
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
FY23 RWHAP Part A Non-Competing Continuation Progress Report
FY2023 Ryan White HIV/AIDS Program (RWHAP) Part A Non-Competing Continuation Progress Report.Resource updated 09/19/2023
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
National Monitoring Standards and RWHAP Part B Manual Recipients
This HRSA technical assistance webinar provided a high level overview of updates made to both the National Monitoring Standards (NMS) and the Ryan White HIV/AIDS Program (RWHAP) Part B Manual. Release of the NMS is forthcoming.Resource updated 08/21/2023
-
Imagine: Ending HIV. It’s Possible.
Imagine: Ending HIV. It’s Possible is the name of a new, national campaign to encourage and energize the HIV workforce to achieve the national goal of ending the HIV epidemic.Blog updated 06/30/2022
-
Imagine: Ending HIV. It's Possible.
Kickoff of a national campaign to showcase how RWHAP leaders have been innovating to achieve the goal of ending the HIV epidemic.Resource updated 03/15/2023
-
The Reach of HIV Provider Training
Each year, over 50,000 HIV care providers receive AETC HIV training to better equip them to deliver HIV care to people with HIV.Blog updated 08/19/2022
-
Long-Acting Injectable Antiretroviral Therapy: Coverage and Cost-Sharing Considerations for RWHAP Clients
Fact sheet on the different coverage and cost-sharing considerations for LAI ART across public and private payers.Resource updated 09/19/2023
-
National Monitoring Standards for RWHAP Part A Recipients
This HRSA technical assistance webinar was to provide a high level overview of updates made to the National Monitoring Standards (NMS). Release of the NMS is forthcoming.Resource updated 08/21/2023